<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02454452</url>
  </required_header>
  <id_info>
    <org_study_id>CEIC 2012/068</org_study_id>
    <nct_id>NCT02454452</nct_id>
  </id_info>
  <brief_title>Comparison of Radiofrequency, Vein Stripping and CHIVA for Venous Insufficency</brief_title>
  <official_title>Comparative Randomized Clinical Study to Evaluate the Efficacy of Radiofrequency vs Surgical Technique of Internal Saphenous Vein Stripping and CHIVA Technique in the Treatment of Chronic Venous Insufficiency.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled clinical trial aimed to compare the effectiveness and safety of
      radiofrequency, saphenous vein stripping and conservative hemodynamic treatment of venous
      insufficiency (CHIVA) in the treatment of saphenous varicose veins, in terms of absence of
      saphenous vein reflux, patient quality of life and post-surgical complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized controlled trial will compare three surgical techniques (stripping, CHIVA and
      radiofrequency) for the treatment of varicose veins which are currently considered
      interchangeable standards of care.

      The trial will include symptomatic patients with chronic venous insufficiency and saphenous
      vein insufficiency confirmed by Doppler with diameter greater than 4 mm.

      Clinical assessments will be made on first and seventh day after surgery, and then at months
      1, 6, 12 and 24. The primary endpoint of the study is the absence of venous reflux in the
      great saphenous vein segment above-knee. Secondary variables will include VAS for pain and
      quality of life as assessed by the SF 36 and CIVIQ questionnaires validated in Spanish
      language. Ultrasound scans will be done the first week and after 1, 6, 12 and 24 months.
      Intra- and postoperative complications will be recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2013</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Absence of venous reflux</measure>
    <time_frame>2 years</time_frame>
    <description>Absence of venous reflux by duplex ultrasound</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CIVIQ</measure>
    <time_frame>2 years</time_frame>
    <description>Venous quality of Life questionnaire - Spanish validated version</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VCSS</measure>
    <time_frame>2 years</time_frame>
    <description>Venous Clinical Severity Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>1 month</time_frame>
    <description>Hematoma, echymosis, infection, bleeding, induration, neuritic pain</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">225</enrollment>
  <condition>Varicose Veins</condition>
  <arm_group>
    <arm_group_label>Saphenous vein stripping</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Saphenous venous stripping surgical technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHIVA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conservative hemodynamic treatment venous insufficiency (CHIVA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiofrequency</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Radiofrequency treatment applied to the vein with VNUS Closure Fast catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiofrequency</intervention_name>
    <description>Radiofrequency treatment applied to the vein with VNUS Closure Fast catheter</description>
    <arm_group_label>Radiofrequency</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Saphenous vein stripping</intervention_name>
    <description>Saphenous vein stripping</description>
    <arm_group_label>Saphenous vein stripping</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CHIVA</intervention_name>
    <description>conservative hemodynamic treatment venous insufficiency</description>
    <arm_group_label>CHIVA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Insufficiency of internal major saphenous vein, confirmed by diameter greater than or
             equal to 4 mm, assessed by Eco- Dupplex.

          -  Age &gt; 18 years

          -  Informed consent

        Exclusion Criteria:

          -  Recurrent varicose veins

          -  Post-thrombotic syndrome.

          -  Patients with active malignancies or severe ischemic heart disease.

          -  Serious liver disease

          -  Thrombophilia.

          -  Serious psychiatric diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena González Cañas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Corporacion Parc Taulí</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de Sabadell</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2015</study_first_submitted>
  <study_first_submitted_qc>May 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2015</study_first_posted>
  <last_update_submitted>August 17, 2017</last_update_submitted>
  <last_update_submitted_qc>August 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Elena González Cañas</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Varicose Veins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

